未登录 Optimal tissue quantity for molecular ancillary studies in multicenter clinical trials in gynecological oncology: Experience of the GINECO pathologists' group 妇科肿瘤学多中心临床试验中分子辅助研究所需的最优组织量：GINECO病理学家组经验 Trecourt, Alexis; Bataillon, Guillaume; Treilleux, Isabelle; Jeanne, Corinne; Montoto-Grillot, Christine; Degnieau, Alexandre; Glais, Eloise; Pujade-Lauraine, Eric; Ray-Coquard, Isabelle; Just, Pierre Alexandre; Genestie, Catherine 分享 收藏
分享 收藏
Incorporating immune checkpoint inhibitors in epithelial ovarian cancer 将免疫检查点抑制剂应用于上皮性卵巢癌 Bogani, Giorgio; Moore, Kathleen N.; Ray-Coquard, Isabelle; Lorusso, Domenica; Matulonis, Ursula A.; Ledermann, Jonathan A.; Gonzalez-Martin, Antonio; Kurtz, Jean-Emmanuel; Pujade-Lauraine, Eric; Scambia, Giovanni; Caruso, Giuseppe; Raspagliesi, Francesco; Colombo, Nicoletta; Monk, Bradley J. 分享 收藏
Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial 晚期上皮性卵巢癌患者中，诊断时循环肿瘤DNA的预后价值及其在完成一周期新辅助化疗后的早期下降情况。一项CHIVA II期GINECO试验的辅助分析。 Azais, Henri; Brochard, Camille; Taly, Valerie; Benoit, Louise; Ferron, Gwenael; Ray-Coquard, Isabelle; You, Benoit; Abadie-Lacourtoisie, Sophie; Lebreton, Coriolan; Venat, Laurence; Louvet, Christophe; Favier, Laure; Blonz, Cyriac; Dohollou, Nadine; Malaurie, Emmanuelle; Dubot, Coraline; Kurtz, Jean-Emmanuel; Pujade-Lauraine, Eric; Rouleau, Etienne; Leary, Alexandra; Bats, Anne-Sophie; Blons, Helene; Laurent-Puig, Pierre 分享 收藏
The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research Moniot, Aurelie; Schneider, Christophe; Chardin, Laure; Yaniz-Galende, Elisa; Genestie, Catherine; Etiennot, Marion; Henry, Auberi; Drelon, Coralie; Le Formal, Audrey; Langlois, Benoit; Venat, Laurence; Louvet, Christophe; Favier, Laure; Lortholary, Alain; Berton-Rigaud, Dominique; Dohollou, Nadine; Desauw, Christophe; Fabbro, Michel; Malaurie, Emmanuelle; Dubot, Coraline; Kurtz, Jean Emmanuel; Bonichon Lamichhane, Nathalie; Pujade-Lauraine, Eric; Jeanne, Albin; Leary, Alexandra; Dedieu, Stephane 分享 收藏
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer 低覆盖率全基因组检测卵巢癌同源重组缺陷的临床评价 Boidot, Romain; Blum, Michael G. B.; Wissler, Marie-Pierre; Gottin, Celine; Ruzicka, Jiri; Chevrier, Sandy; Delhomme, Tiffany M.; Audoux, Jerome; Jeanniard, Adrien; Just, Pierre-Alexandre; Harter, Philipp; Pignata, Sandro; Gonzalez-Martin, Antonio; Marth, Christian; Maenpaa, Johanna; Colombo, Nicoletta; Vergote, Ignace; Fujiwara, Keiichi; Duforet-Frebourg, Nicolas; Bertrand, Denis; Philippe, Nicolas; Ray-Coquard, Isabelle; Pujade-Lauraine, Eric 分享 收藏
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer Zebic, Danka Sinikovic; Tjokrowidjaja, Angelina; Francis, Katherine Elizabeth; Friedlander, Michael; Gebski, Val; Lortholary, Alain; Joly, Florence; Hasenburg, Annette; Mirza, Mansoor; Denison, Ursula; Cecere, Sabrina Chiara; Ferrero, Annamaria; Pujade-Lauraine, Eric; Lee, Chee Khoon 分享 收藏
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ ENGOT-ov38): a phase IIIb trial 先前接受PARP抑制剂 (OReO/ ENGOT-ov38) 治疗的铂敏感复发性卵巢癌患者的维持olaparib再激发: IIIb期试验 Pujade-Lauraine, E.; Selle, F.; Scambia, G.; Asselain, B.; Marme, F.; Lindemann, K.; Colombo, N.; Madryl, R.; Glasspool, R.; Vergote, I.; Korach, J.; Lheureux, S.; Dubot, C.; Oaknin, A.; Zamagni, C.; Heitz, F.; Gladieff, L.; Rubio-Perez, M. J.; Scollo, P.; Blakeley, C.; Shaw, B.; Ray-Coquard, I; Redondo, A. 分享 收藏
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles Pozzorini, Christian; Andre, Gregoire; Coletta, Tommaso; Buisson, Adrien; Bieler, Jonathan; Ferrer, Loic; Kempfer, Rieke; Saintigny, Pierre; Harle, Alexandre; Vacirca, Davide; Barberis, Massimo; Gilson, Pauline; Roma, Cristin; Saitta, Alexandra; Smith, Ewan; Barras, Floriane Consales; Ripol, Lucia; Fritzsche, Martin; Marques, Ana Claudia; Alkodsi, Amjad; Marin, Ray; Normanno, Nicola; Grimm, Christoph; Mullauer, Leonhard; Harter, Philipp; Pignata, Sandro; Gonzalez-Martin, Antonio; Denison, Ursula; Fujiwara, Keiichi; Vergote, Ignace; Colombo, Nicoletta; Willig, Adrian; Pujade-Lauraine, Eric; Just, Pierre-Alexandre; Ray-Coquard, Isabelle; Xu, Zhenyu 分享 收藏
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial Callens, Celine; Rodrigues, Manuel; Briaux, Adrien; Frouin, Eleonore; Eeckhoutte, Alexandre; Pujade-Lauraine, Eric; Renault, Victor; Stoppa-Lyonnet, Dominique; Bieche, Ivan; Bataillon, Guillaume; Karayan-Tapon, Lucie; Rochelle, Tristan; Heitz, Florian; Cecere, Sabrina Chiara; Perez, Maria Jesus Rubio; Grimm, Christoph; Nottrup, Trine Jakobi; Colombo, Nicoletta; Vergote, Ignace; Yonemori, Kan; Ray-Coquard, Isabelle; Stern, Marc-Henri; Popova, Tatiana 分享 收藏
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial 奥拉帕利联合贝伐单抗一线维持治疗卵巢癌: PAOLA-1/ENGOT-ov25试验的最终总生存期结果 Ray-Coquard, I.; Leary, A.; Pignata, S.; Cropet, C.; Gonzalez-Martin, A.; Marth, C.; Nagao, S.; Vergote, I.; Colombo, N.; Maenpaa, J.; Selle, F.; Sehouli, J.; Lorusso, D.; Alia, E. M. Guerra; Bogner, G.; Yoshida, H.; Lefeuvre-Plesse, C.; Buderath, P.; Mosconi, A. M.; Lortholary, A.; Burges, A.; Medioni, J.; El-Balat, A.; Rodrigues, M.; Park-Simon, T. -W.; Dubot, C.; Denschlag, D.; You, B.; Pujade-Lauraine, E.; Harter, P. 分享 收藏
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial Loverix, Liselore; Vergote, Ignace; Busschaert, Pieter; Vanderstichele, Adriaan; Venken, Tom; Boeckx, Bram; Harter, Philipp; Brems, Hilde; Van Nieuwenhuysen, Els; Pignata, Sandro; Baert, Thais; Gonzalez-Martin, Antonio; Han, Sileny; Marth, Christian; Neven, Patrick; Colombo, Nicoletta; Berteloot, Patrick; Maeenpaeae, Johanna; Olbrecht, Siel; Laga, Tina; Sablon, Erwin; Ray-Coquard, Isabelle; Pujade-Lauraine, Eric; Lambrechts, Diether; Van Gorp, Toon 分享 收藏
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy Lequesne, Justine; Joly, Florence; Peron, Julien; Ray-Coquard, Isabelle; Hardy-Bessard, Anne-Claire; Selle, Frederic; Berton, Dominique; Follana, Philippe; Fabbro, Michel; Lortholary, Alain; Pujade-Lauraine, Eric; Lefevre-Arbogast, Sophie; Coquan, Elodie 分享 收藏
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial 来自PAOLA-1/ENGOT-ov25试验的 ≥ 65岁卵巢癌患者维持奥拉帕尼和贝伐单抗的疗效和安全性 Sabatier, Renaud; Rousseau, Frederique; Joly, Florence; Cropet, Claire; Montegut, Coline; Frindte, Johanna; Cinieri, Saverio; Alia, Eva M. Guerra; Polterauer, Stephan; Yoshida, Hiroyuki; Vergote, Ignace; Colombo, Nicoletta; Hietanen, Sakari; Largillier, Remi; Canzler, Ulrich; Gratet, Alain; Marme, Frederik; Favier, Laure; Pujade-Lauraine, Eric; Ray-Coquard, Isabelle 分享 收藏
Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis 高级别卵巢癌中BRCA1和BRCA2突变位置与奥拉帕尼和贝伐单抗维持治疗获益的关系: III期PAOLA-1/ENGOT-ov25试验亚组探索性分析 Labidi-Galy, S. I.; Rodrigues, M.; Sandoval, J. L.; Kurtz, J. E.; Heitz, F.; Mosconi, A. M.; Romero, I.; Denison, U.; Nagao, S.; Vergote, I.; Parma, G.; Nottrup, T. J.; Rouleau, E.; Garnier, G.; El-Balat, A.; Zamagni, C.; Martin-Lorente, C.; Pujade-Lauraine, E.; Fievet, A.; Ray-Coquard, I. L. 分享 收藏
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial Frenel, J. S.; Kim, J. W.; Aryal, N.; Asher, R.; Berton, D.; Vidal, L.; Pautier, P.; Ledermann, J. A.; Penson, R. T.; Oza, A. M.; Korach, J.; Huzarski, T.; Pignata, S.; Colombo, N.; Park-Simon, T. W.; Tamura, K.; Sonke, G. S.; Freimund, A. E.; Lee, C. K.; Pujade-Lauraine, E. 分享 收藏
A multicenter evaluation of a low pass whole genome sequencing-based solution for homologous recombination deficiency detection Buisson, A.; Saintigny, P.; Pujade-Lauraine, E.; Grillot, C. Montoto; Varcica, D.; Barberis, M.; Colombo, N.; Harle, A.; Gilson, P.; Roma, C.; Bergantino, F.; Harter, P.; Pignata, S.; Martin, A. J. Gonzalez; Schauer, C.; Fujiwara, K.; Vergote, I. B.; Juhler-Nottrup, T. J.; Just, P-A.; Ray-Coquard, I. L. 分享 收藏
Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) Ray-Coquard, I. L.; Leary, A.; Pignata, S.; Cropet, C.; Gonzalez Martin, A. J.; Bogner, G.; Yoshida, H.; Vergote, I. B.; Colombo, N.; Maenpaa, J.; Selle, F.; Schmalfeldt, B.; Scambia, G.; Guerra Alia, E. M.; Lefeuvre-Plesse, C.; Belau, A.; Lortholary, A.; Gropp-Meier, M.; Pujade-Lauraine, E.; Harter, P. 分享 收藏
Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study Falandry, Claire; Pommeret, Fanny; Gladieff, Laurence; Tinquaut, Fabien; Lorusso, Domenico; Mouret-Reynier, Marie-Ange; D'Hondt, Veronique; Mollon-Grange, Delphine; Floquet, Anne; Abadie-Lacourtoisie, Sophie; Brachet, Pierre-Emmanuel; Stefani, Laetitia; Rousseau, Frederique; Frenel, Jean-Sebastien; Del Piano, Francesco; Komulainen, Marja; Warkus, Thomas; Tredan, Olivier; Pujade-Lauraine, Eric; Freyer, Gilles 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
gynecologic oncology.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏